Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Int J Mol Sci. 2020 Mar 11;21(6):1908. doi: 10.3390/ijms21061908.
People are living longer than ever. Consequently, they have a greater chance for developing a functional impairment or aging-related disease, such as a neurodegenerative disease, later in life. Thus, it is important to identify and understand mechanisms underlying aging as well as the potential for rejuvenation. Therefore, we used next-generation sequencing to identify differentially expressed microRNAs (miRNAs) in serum exosomes isolated from young (three-month-old) and old (22-month-old) rats and then used bioinformatics to explore candidate genes and aging-related pathways. We identified 2844 mRNAs and 68 miRNAs that were differentially expressed with age. TargetScan revealed that 19 of these miRNAs are predicated to target the 766 mRNAs. Pathways analysis revealed signaling components targeted by these miRNAs: mTOR, AMPK, eNOS, IGF, PTEN, p53, integrins, and growth hormone. In addition, the most frequently predicted target genes regulated by these miRNAs were EIF4EBP1, insulin receptor, PDK1, PTEN, paxillin, and IGF-1 receptor. These signaling pathways and target genes may play critical roles in regulating aging and lifespan, thereby validating our analysis. Understanding the causes of aging and the underlying mechanisms may lead to interventions that could reverse certain aging processes and slow development of aging-related diseases.
人们比以往任何时候都活得更久。因此,他们在晚年更有可能患上与功能障碍或衰老相关的疾病,如神经退行性疾病。因此,识别和理解衰老的机制以及恢复活力的潜力非常重要。因此,我们使用下一代测序技术来鉴定来自年轻(三个月大)和年老(22 个月大)大鼠血清外泌体中差异表达的 microRNAs(miRNAs),然后使用生物信息学方法来探索候选基因和与衰老相关的途径。我们鉴定出了 2844 个 mRNAs 和 68 个 miRNAs,这些 miRNAs 的表达与年龄有关。TargetScan 显示,其中 19 个 miRNAs 被预测为靶向 766 个 mRNAs。通路分析揭示了这些 miRNAs 靶向的信号成分:mTOR、AMPK、eNOS、IGF、PTEN、p53、整合素和生长激素。此外,这些 miRNAs 最常预测的靶基因是 EIF4EBP1、胰岛素受体、PDK1、PTEN、paxillin 和 IGF-1 受体。这些信号通路和靶基因可能在调节衰老和寿命方面发挥关键作用,从而验证了我们的分析。了解衰老的原因和潜在机制可能会导致干预措施的出现,这些干预措施可能会逆转某些衰老过程并减缓与衰老相关的疾病的发展。